Adrenal suppression from high-dose inhaled fluticasone propionate in children with asthma

European Respiratory Journal

Volumn 21, Issue 4, 2003, Pages 633-636

  Sim, D ^a   Griffiths, A ^a   Armstrong, D ^a   Clarke, C ^a   Rodda, C ^a   Freezer, N ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

Adrenal suppression; Asthma; Children; Flixotide

Indexed keywords

BECLOMETASONE; BUDESONIDE; CORTICOSTEROID DERIVATIVE; FLUTICASONE PROPIONATE; HYDROCORTISONE; TETRACOSACTIDE;

ADOLESCENT; ADRENAL CORTEX INSUFFICIENCY; ADRENAL SUPPRESSION; ADULT; ARTICLE; ASTHMA; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG EFFECT; DRUG EFFICACY; DRUG MEGADOSE; FEMALE; HUMAN; HYDROCORTISONE BLOOD LEVEL; MALE; METERED DOSE INHALER; PREVALENCE; PRIORITY JOURNAL; PROVOCATION TEST;

EID: 0037383953     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.03.00306302     Document Type: Article

References (33)

1. National Asthma Council. Asthma Management Handbook. 4th Edn. Melbourne, National Asthma Council, 2002.
2. British Thoracic Society. The British guidelines on asthma management. Thorax 1997; 52: Suppl. 1, S1-S2.
3. Calpin C, Macarthur C, Stephens D, Feldman W, Parkin PC. Effectiveness of prophylactic inhaled steroids in childhood asthma: a systemic review of the literature. J Allergy Clin Immunol 1997; 100: 452-457.
4. Lipworth BJ. Systemic adverse effects of inhaled corticosteroid therapy - a systematic review and meta-analysis. Arch Intern Med 1999; 159: 941-955.
5. Priftis K, Milner AD, Conway E, Honour JW. Adrenal function in asthma. Arch Dis Child 1990; 65: 838-840.
6. Doull IJM, Freezer NJ, Holgate ST. Growth of prepubertal children with mild asthma treated with inhaled beclomethasone dipropionate. Am J Respir Crit Care Med 1994; 151: 1715-1719.
7. Lipworth BJ. New perspectives on inhaled drug delivery and systemic bioactivity. Thorax 1995; 50: 105-110.
8. Meibohm B, Mollmann H, Wagner M, Hochhaus G, Mollman A, Derendorf H. The clinical pharmacology of fluticasone propionate. Rev Contemp Pharmacother 1998; 9: 535-549.
9. Todd GRC. Side-effects of high-dose fluticasone propionate in children. Eur Respir J 1999; 13: 707-709.
10. O'Byrne PM, Pedersen S. Measuring efficacy and safety of different inhaled corticosteroid preparations. J Allergy Clin Immunol 1998; 102: 879-886.
11. Thorsson L, Dahlstrom K, Edsbacker S, Kallen A, Paulson J, Wiren JE. Pharmacokinetics and systemic effects of inhaled fluticasone propionate in healthy subjects. Br J Clin Pharmacol 1997; 43: 155-161.
12. Ferguson AC, Spier S, Manjra A, Versteegh F, Mark S, Zhang P. Efficacy and safety of high-dose inhaled steroids in children with asthma: a comparison of fluticasone propionate and budesonide. J Pediatr 1999; 134: 422-426.
13. Lipworth BJ, Clark DJ, MacFarlane LC. Adrenocortical activity with repeated twice daily dosing of fluticasone propionate and budesonide given via a large volume spacer to asthmatic school children. Thorax 1997; 52: 686-689.
14. Todd G, Dunlop K, McNaboe J, Ryan MF, Carson D, Shields MD. Growth and adrenal suppression in asthmatic children treated with high-dose fluticasone propionate. Lancet 1996; 348: 27-29.
15. Taylor AV, Laoprasert N, Zimmerman D, Sachs M. Adrenal suppression secondary to inhaled fluticasone propionate. Ann Allergy Asthma Immunol 1999; 83: 68-70.
16. Zimmerman B, Gold M, Wherrett D, Hanna A. Adrenal suppression in two patients with asthma treated with low doses of the inhaled steroid fluticasone propionate. J Allergy Clin Immunol 1998; 101: 425-426.
17. Williams J. Fluticasone propionate in the treatment of asthma in children: efficacy and safety. Rev Contemp Pharmacother 1998; 9: 581-590.
18. Jonetz-Mentzel L, Wiedemann G. Establishment of reference ranges for cortisol in neonates, infants, children and adolescents. Eur J Clin Chem Biochem 1993; 31: 525-529.
19. Fisher DA, Horton R, Ladenson PW, Nelson JC, Odell WD, eds. Endocrinology - Test Selection and Interpretation. 2nd Edn. Quest Diagnostics Incorporated, San Juan, 1998; p. 71.
20. Tordjman K, Jaffe A, Grazas N, Apter C, Stern N. The role of low dose (1 mcg) adrenocorticotropin test in the evaluation of patients with pituitary diseases. J Clin Endocrinol Metab 1995; 80: 1301-1305.
21. Walker JM, Hughes IA. Tests and normal values in paediatric endocrinology. In: Brook CJD, ed. Clinical Paediatric Endocrinology. London, Blackwell Science, 1995; pp. 789-790.
22. Clayton RN. Diagnosis of adrenal insufficiency. BMJ 1989; 298: 271-272.
23. Fitzgerald D, van Asperen P, Mellis C, Honner M, Smith L, Ambler G. Fluticasone propionate 750 mcg/day versus beclomethasone dipropionate 1500 mcg/day: comparison of efficacy and adrenal function in paediatric asthma. Thorax 1998; 53: 656-661.
24. Kannisto S, Korpi M, Remes K, Voutilainen R. Adrenal suppression, evaluated by a low dose adrenocorticotropin test, and growth in asthmatic children treated with inhaled steroids. J Clin Endocrinol Metab 2000; 85: 652-657.
25. Broide J, Soferman S, Kivity S, et al. Low dose adrenocorticotropin test reveals impaired adrenal function in patients taking inhaled corticosteroids. J Clin Endocrinol Metab 1995; 80: 1243-1246.
26. Newman SP, Millar AB, Lennard-Jones TR, Moren F, Clarke SW. Improvement of pressurised aerosol deposition with Nebuhaler spacer device. Thorax 1984; 39: 935-941.
27. Newman SP, Moren F, Trofast E, Talaee N, Clarke SW. Deposition and clinical efficacy of terbutaline sulfate from Turbuhaler. A new multi-dose powder inhaler. Eur Respir J 1989; 2: 247-252.
28. Crowley S, Hindmarsh PC, Holownia JW. The use of low doses of ACTH in the investigation of adrenal function in man. J Endocrinol 1991; 130: 475-479.
29. Rasmuson S, Olsson T, Hagg E. A low dose ACTH test to assess the function of the hypothalamic-pituitary-adrenal axis. Clin Endocrinol 1996; 44: 151-156.
30. Agwu JC, Spoudeas H, Hindmarsh PC, Pringle PJ, Brook CGD. Tests of adrenal insufficiency. Arch Dis Child 1999; 80: 330-333.
31. Abdu T, Elhadd T, Neary R, Clayton R. Comparison of the low dose short synacthen test (1 mcg), the conventional dose short synacthen test (250 mcg) and the insulin tolerance test for assessment of the hypothalamo-pituitary-adrenal axis in patients with pituitary disease. J Clin Endocrinol Metab 1999; 84: 838-843.
32. Hurel SJ, Thompson CJ, Watson J, Harris M, Bayliss PH, Kendall-Taylor P. The short synacthen test and insulin stress tests in the assessment of the hypothalamic-pituitary-adrenal axis. Clin Endocrinol 1996; 44: 141-146.
33. Brown PH, Blundell G, Greening AP, Crompton GK. Screening for hypothalamo-pituitary-adrenal axis suppression in asthmatics taking high dose inhaled corticosteroids. Respir Med 1991; 85: 511-516.